Article

Morning stiffness for assessing RA: Utility varies with activity

The duration of morning stiffness in patients who have rheumatoid arthritis (RA) correlates better with other patient-reported outcomes than with joint counts and erythrocyte sedimentation rate (ESR).

The duration of morning stiffness in patients who have rheumatoid arthritis (RA) correlates better with other patient-reported outcomes than with joint counts and erythrocyte sedimentation rate (ESR). As an individual variable, morning stiffness duration has a moderate ability to differentiate active RA from inactive RA.

Khan and coworkers sought to determine whether assessing morning stiffness in the routine evaluation of patients with RA remains worthwhile, noting conflicting reports about the relationship between morning stiffness duration and active RA. They correlated the severity of morning stiffness with RA activity as assessed by the Disease Activity Score (DAS28). They also explored whether including morning stiffness duration in the Routine Assessment of Patient Index Data 3 (RAPID3) is useful. Information came from a database of 5439 patients in 24 countries.

Morning stiffness duration was moderately correlated with pain; general health; and Health Activity Questionnaire, RAPID3, and DAS28 scores. It was weakly correlated with fatigue, joint counts, and ESR. Morning stiffness duration varied among patients with different RA disease activity states.

The authors noted that morning stiffness is a complex symptom and that assessment of morning stiffness duration in patients with low RAPID3 scores may be clinically relevant.

Related Videos
Uncovering the Role of COVID-19 in Rheumatic Disease, with Leonard Calabrese, DO
Comparing Treatment Options for Psoriatic Arthritis with Philip Mease, MD
Considering Viral Infections in Patients With Rheumatic Disease With Leonard Calabrese, DO
Leonard H. Calabrese, DO, Professor of Medicine and Vice Chair, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University
Alvin Wells, MD, PhD: Making Informed Treatment Decisions With New Testing Strategies
Alvin Wells, MD, PhD
Upcoming Research in PsA, AxSpa, with Philip Mease, MD
Philip Mease, MD, Clinical Professor, University of Washington School of Medicine and Director, Rheumatology Research, Swedish Medical Center
© 2024 MJH Life Sciences

All rights reserved.